Remdesivir could be granted conditional marketing authorisation ‘in the coming days’, says EMA

The investigational antiviral medicine, remdesivir, may be granted a conditional marketing authorisation as a treatment for COVID-19 “in the coming days”, the head of the European Medicines Agency has said.…